Collective Weekly
The Triangle edition · Issue of August 14, 2025
What organizations in the Triangle published in the week to Aug 14, and where to turn up in the seven days after. Their words, their pictures, their bylines.
This week
17 stories from 11 organizations, found on their own sites between Aug 7 and Aug 14. One pick, then every one of them by the day it went up.
Phase 1/2a study on Lisavanbulin Published in Journal Cell Reports Medicine - Glioblastoma Treatment & Research
In June 2025, Cell Reports Medicine published the results of an international clinical trial investigating Lisavanbulin, a new experimental pill for people with glioblastoma and other high-grade gliomas. Glioblastoma is an aggressive brain cancer that almost always returns after initial treatment with the current standard of care, comprised of surgery, radiation, and chemotherapy. Once it recurs, treatment options are limited and outcomes are often poor. This study set out to determine the safest daily dose of Lisavanbulin, to see whether it could help control tumor growth.
Collective Weekly
The Triangle edition
Every Thursday: the stories, posts, people and events from the organizations working near you, in their own words.
One email a week. Unsubscribe anytime.
Have you ever wondered who's behind the camera for so many of our best photos?
We're here and ready to serve you with a smile this Wednesday morning!
Nutrition Education
From the causes
5 causes published something this week. The newest from each.
Have you ever wondered who's behind the camera for so many of our best photos? · Aug 14 · 6 stories this week
Amazonian Forest Farming: Records of the Past Inform Management of Today · Aug 11 · 1 story this weekAugust 2025 Webinar – Understanding Changes in PIT Count Numbers and Federal Funding · Aug 12 · 1 story this week